The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
Academic partnerships | Pharmacology | Brain
Theranexus, a CEA-born biopharmaceutical company,
signs a three-year research partnership agreement with the Collège de France.
While working at the François Jacob Institute of Biology, Franck Mouthon and Mathieu Charveriat discovered the important role played by non-neuronal cells, called glial cells, in the neuronal response to psychotropic medications. Their seminal research showed that by modulating the organization of glial cells, it is possible to greatly improve neuronal response to and in turn the effectiveness of psychotropic medications. That research also moved them to co-found and share the direction of Theranexus, a company now joining forces with the Collège de France for a three-year joint research effort.
That collaboration will focus on the impact of glial cells on neuronal activity. Dr. Nathalie Rouach will supervise the research, to be carried out at the Center of Interdisciplinary Research in Biology directed by Prof. Alain Prochiantz.
This research program will include a National Association for Research and Technology (ANRT) doctoral fellowship program (Cifre).
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.